Build Your Comparison

Side-by-side financial analysis
PROV logo
PROV
ICE logo
ICE
CME logo
CME
WAFD logo
WAFD
JPM logo
JPM
Try popular comparisons:

Stock Comparison

PROV vs ICE vs CME vs WAFD vs JPM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PROV
Provident Financial Holdings, Inc.

Banks - Regional

Financial ServicesNASDAQ • US
Market Cap$109M
5Y Perf.+27.6%
ICE
Intercontinental Exchange, Inc.

Financial - Data & Stock Exchanges

Financial ServicesNYSE • US
Market Cap$79.60B
5Y Perf.+53.4%
CME
CME Group Inc.

Financial - Data & Stock Exchanges

Financial ServicesNASDAQ • US
Market Cap$97.79B
5Y Perf.+65.8%
WAFD
WaFd, Inc.

Banks - Regional

Financial ServicesNASDAQ • US
Market Cap$2.85B
5Y Perf.+38.1%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$896.00B
5Y Perf.+241.0%

PROV vs ICE vs CME vs WAFD vs JPM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PROV logoPROV
ICE logoICE
CME logoCME
WAFD logoWAFD
JPM logoJPM
IndustryBanks - RegionalFinancial - Data & Stock ExchangesFinancial - Data & Stock ExchangesBanks - RegionalBanks - Diversified
Market Cap$109M$79.60B$97.79B$2.85B$896.00B
Revenue (TTM)$60M$12.64B$6.76B$1.39B$280.33B
Net Income (TTM)$7M$3.30B$4.24B$243M$57.05B
Gross Margin67.8%61.9%86.3%52.8%60.0%
Operating Margin16.2%38.7%65.6%22.4%25.9%
Forward P/E15.4x17.3x22.0x11.4x14.4x
Total Debt$213M$20.28B$3.76B$1.82B$942.38B
Cash & Equiv.$53M$837M$4.42B$657M$343.34B

PROV vs ICE vs CME vs WAFD vs JPMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PROV
ICE
CME
WAFD
JPM
StockJun 20Jun 26Return
Provident Financial… (PROV)100127.6+27.6%
Intercontinental Ex… (ICE)100153.4+53.4%
CME Group Inc. (CME)100165.8+65.8%
WaFd, Inc. (WAFD)100138.1+38.1%
JPMorgan Chase & Co. (JPM)100341.0+241.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: PROV vs ICE vs CME vs WAFD vs JPM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CME leads in 3 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and dividend income and shareholder returns. Provident Financial Holdings, Inc. is the stronger pick specifically for capital preservation and lower volatility. ICE, WAFD, and JPM also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
🥇CME emerged as the overall leader. Track its performance:
PROV
Provident Financial Holdings, Inc.
The Banking Pick

PROV is the #2 pick in this set and the best alternative if defensive and bank quality is your priority.

  • Beta 0.21, yield 3.3%, current ratio 0.06x
  • NIM 2.8% vs JPM's 2.2%
  • Beta 0.21 vs JPM's 0.94, lower leverage
Best for: defensive and bank quality
ICE
Intercontinental Exchange, Inc.
The Banking Pick

ICE ranks third and is worth considering specifically for growth exposure and sleep-well-at-night.

  • Rev growth 7.5%, EPS growth 20.7%
  • Lower volatility, beta 0.35, Low D/E 69.9%, current ratio 1.02x
  • 7.5% NII/revenue growth vs WAFD's -1.6%
Best for: growth exposure and sleep-well-at-night
CME
CME Group Inc.
The Banking Pick

CME carries the broadest edge in this set and is the clearest fit for quality and dividends.

  • Efficiency ratio 0.2% vs PROV's 0.5% (lower = leaner)
  • 4.1% yield, 15-year raise streak, vs WAFD's 2.8%
  • Efficiency ratio 0.2% vs PROV's 0.5%
Best for: quality and dividends
WAFD
WaFd, Inc.
The Banking Pick

WAFD is the clearest fit if your priority is income & stability.

  • Dividend streak 16 yrs, beta 0.66, yield 2.8%
  • +32.5% vs ICE's -20.4%
Best for: income & stability
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM is the clearest fit if your priority is long-term compounding and valuation efficiency.

  • 465.8% 10Y total return vs CME's 262.4%
  • PEG 0.81 vs WAFD's 3.69
  • Lower P/E (14.4x vs 22.0x), PEG 0.81 vs 1.60
Best for: long-term compounding and valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthICE logoICE7.5% NII/revenue growth vs WAFD's -1.6%
ValueJPM logoJPMLower P/E (14.4x vs 22.0x), PEG 0.81 vs 1.60
Quality / MarginsCME logoCMEEfficiency ratio 0.2% vs PROV's 0.5% (lower = leaner)
Stability / SafetyPROV logoPROVBeta 0.21 vs JPM's 0.94, lower leverage
DividendsCME logoCME4.1% yield, 15-year raise streak, vs WAFD's 2.8%
Momentum (1Y)WAFD logoWAFD+32.5% vs ICE's -20.4%
Efficiency (ROA)CME logoCMEEfficiency ratio 0.2% vs PROV's 0.5%

PROV vs ICE vs CME vs WAFD vs JPM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Fintech Stocks Theme

These companies are key players in the Fintech Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
PROVProvident Financial Holdings, Inc.
FY 2025
Debit Card
53.2%$1M
Deposit Account
46.8%$1M
ICEIntercontinental Exchange, Inc.
FY 2025
Fixed Income And Data Services Segment
51.1%$1.4B
Exchanges Segment
38.8%$1.0B
Mortgage Technology Segment
10.1%$269M
CMECME Group Inc.
FY 2025
clearing and transaction fees
81.0%$5.3B
MarketData
12.3%$803M
OtherRevenue
6.7%$436M
WAFDWaFd, Inc.

Segment breakdown not available.

JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000

PROV vs ICE vs CME vs WAFD vs JPM — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCMELAGGINGICE

Income & Cash Flow (Last 12 Months)

CME leads this category, winning 4 of 5 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 4661.3x PROV's $60M. CME is the more profitable business, keeping 62.8% of every revenue dollar as net income compared to PROV's 11.0%.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …CME logoCMECME Group Inc.WAFD logoWAFDWaFd, Inc.JPM logoJPMJPMorgan Chase & …
RevenueTrailing 12 months$60M$12.6B$6.8B$1.4B$280.3B
EBITDAEarnings before interest/tax$12M$6.5B$4.7B$277M$81.4B
Net IncomeAfter-tax profit$7M$3.3B$4.2B$243M$57.0B
Free Cash FlowCash after capex$9M$4.3B$4.4B$215M$100.9B
Gross MarginGross profit ÷ Revenue+67.8%+61.9%+86.3%+52.8%+60.0%
Operating MarginEBIT ÷ Revenue+16.2%+38.7%+65.6%+22.4%+25.9%
Net MarginNet income ÷ Revenue+11.0%+26.1%+62.8%+17.5%+20.4%
FCF MarginFCF ÷ Revenue+15.3%+33.9%+64.4%+15.5%+36.0%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year+69.2%+23.1%+21.4%+46.3%+16.0%
CME leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

WAFD leads this category, winning 3 of 7 comparable metrics.

At 14.1x trailing earnings, WAFD trades at a 42% valuation discount to ICE's 24.4x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs WAFD's 4.58x — a lower PEG means you pay less per unit of expected earnings growth.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …CME logoCMECME Group Inc.WAFD logoWAFDWaFd, Inc.JPM logoJPMJPMorgan Chase & …
Market CapShares × price$109M$79.6B$97.8B$2.9B$896.0B
Enterprise ValueMkt cap + debt − cash$269M$99.0B$97.1B$4.0B$1.50T
Trailing P/EPrice ÷ TTM EPS18.40x24.36x24.15x14.10x16.00x
Forward P/EPrice ÷ next-FY EPS est.15.41x17.34x21.98x11.35x14.40x
PEG RatioP/E ÷ EPS growth rate2.74x1.76x4.58x0.90x
EV / EBITDAEnterprise value multiple21.77x15.34x21.56x13.41x18.36x
Price / SalesMarket cap ÷ Revenue1.81x6.30x15.00x2.02x3.20x
Price / BookPrice ÷ Book value/share0.90x2.77x3.38x0.98x2.47x
Price / FCFMarket cap ÷ FCF13.38x18.56x23.32x13.71x8.88x
WAFD leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

CME leads this category, winning 4 of 9 comparable metrics.

JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $5 for PROV. CME carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), ICE scores 9/9 vs JPM's 5/9, reflecting strong financial health.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …CME logoCMECME Group Inc.WAFD logoWAFDWaFd, Inc.JPM logoJPMJPMorgan Chase & …
ROE (TTM)Return on equity+5.1%+11.6%+15.3%+8.0%+15.9%
ROA (TTM)Return on assets+0.5%+2.3%+2.2%+0.9%+1.3%
ROICReturn on invested capital+1.9%+7.5%+10.2%+3.9%+4.5%
ROCEReturn on capital employed+2.4%+9.5%+3.6%+5.7%+8.9%
Piotroski ScoreFundamental quality 0–969575
Debt / EquityFinancial leverage1.66x0.70x0.13x0.60x2.60x
Net DebtTotal debt minus cash$160M$19.4B-$666M$1.2B$599.0B
Cash & Equiv.Liquid assets$53M$837M$4.4B$657M$343.3B
Total DebtShort + long-term debt$213M$20.3B$3.8B$1.8B$942.4B
Interest CoverageEBIT ÷ Interest expense0.47x6.53x41.55x0.48x0.74x
CME leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

JPM leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $11,816 for PROV. Over the past 12 months, WAFD leads with a +32.5% total return vs ICE's -20.4%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs ICE's 10.4% — a key indicator of consistent wealth creation.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …CME logoCMECME Group Inc.WAFD logoWAFDWaFd, Inc.JPM logoJPMJPMorgan Chase & …
YTD ReturnYear-to-date+8.8%-11.8%+3.2%+17.1%-0.5%
1-Year ReturnPast 12 months+14.5%-20.4%+3.6%+32.5%+21.8%
3-Year ReturnCumulative with dividends+50.9%+34.6%+67.9%+37.6%+138.2%
5-Year ReturnCumulative with dividends+18.2%+30.9%+46.2%+29.5%+118.2%
10-Year ReturnCumulative with dividends+25.8%+195.3%+262.4%+91.9%+465.8%
CAGR (3Y)Annualised 3-year return+14.7%+10.4%+18.9%+11.2%+33.6%
JPM leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CME and WAFD each lead in 1 of 2 comparable metrics.

CME is the less volatile stock with a -0.28 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WAFD currently trades 99.9% from its 52-week high vs ICE's 74.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …CME logoCMECME Group Inc.WAFD logoWAFDWaFd, Inc.JPM logoJPMJPMorgan Chase & …
Beta (5Y)Sensitivity to S&P 5000.21x0.35x-0.28x0.66x0.94x
52-Week HighHighest price in past year$17.42$189.35$329.16$37.10$337.25
52-Week LowLowest price in past year$14.95$136.67$244.56$26.31$262.71
% of 52W HighCurrent price vs 52-week peak+98.2%+74.2%+81.9%+99.9%+95.1%
RSI (14)Momentum oscillator 0–10048.831.940.163.859.1
Avg Volume (50D)Average daily shares traded8K3.2M2.6M525K7.0M
Evenly matched — CME and WAFD each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — CME and WAFD each lead in 1 of 2 comparable metrics.

Analyst consensus: PROV as "Hold", ICE as "Buy", CME as "Hold", WAFD as "Hold", JPM as "Buy". Consensus price targets imply 38.0% upside for ICE (target: $194) vs -6.5% for PROV (target: $16). For income investors, CME offers the higher dividend yield at 4.05% vs ICE's 1.38%.

MetricPROV logoPROVProvident Financi…ICE logoICEIntercontinental …CME logoCMECME Group Inc.WAFD logoWAFDWaFd, Inc.JPM logoJPMJPMorgan Chase & …
Analyst RatingConsensus buy/hold/sellHoldBuyHoldHoldBuy
Price TargetConsensus 12-month target$16.00$194.00$320.80$35.00$339.75
# AnalystsCovering analysts1036361161
Dividend YieldAnnual dividend ÷ price+3.3%+1.4%+4.1%+2.8%+1.9%
Dividend StreakConsecutive years of raises013151615
Dividend / ShareAnnual DPS$0.56$1.93$10.92$1.05$5.95
Buyback YieldShare repurchases ÷ mkt cap+4.1%+1.7%+0.3%+3.6%+3.9%
Evenly matched — CME and WAFD each lead in 1 of 2 comparable metrics.
Key Takeaway

CME leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). WAFD leads in 1 (Valuation Metrics). 2 tied.

Best OverallCME Group Inc. (CME)Leads 2 of 6 categories
Loading custom metrics...

PROV vs ICE vs CME vs WAFD vs JPM: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is PROV or ICE or CME or WAFD or JPM a better buy right now?

For growth investors, Intercontinental Exchange, Inc.

(ICE) is the stronger pick with 7. 5% revenue growth year-over-year, versus -1. 6% for WaFd, Inc. (WAFD). WaFd, Inc. (WAFD) offers the better valuation at 14. 1x trailing P/E (11. 4x forward), making it the more compelling value choice. Analysts rate Intercontinental Exchange, Inc. (ICE) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — PROV or ICE or CME or WAFD or JPM?

On trailing P/E, WaFd, Inc.

(WAFD) is the cheapest at 14. 1x versus Intercontinental Exchange, Inc. at 24. 4x. On forward P/E, WaFd, Inc. is actually cheaper at 11. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus WaFd, Inc. 's 3. 69x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — PROV or ICE or CME or WAFD or JPM?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +118. 2%, compared to +18. 2% for Provident Financial Holdings, Inc. (PROV). Over 10 years, the gap is even starker: JPM returned +465. 8% versus PROV's +25. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — PROV or ICE or CME or WAFD or JPM?

By beta (market sensitivity over 5 years), CME Group Inc.

(CME) is the lower-risk stock at -0. 28β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately -435% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — PROV or ICE or CME or WAFD or JPM?

By revenue growth (latest reported year), Intercontinental Exchange, Inc.

(ICE) is pulling ahead at 7. 5% versus -1. 6% for WaFd, Inc. (WAFD). On earnings-per-share growth, the picture is similar: Intercontinental Exchange, Inc. grew EPS 20. 7% year-over-year, compared to -12. 3% for Provident Financial Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — PROV or ICE or CME or WAFD or JPM?

CME Group Inc.

(CME) is the more profitable company, earning 62. 0% net margin versus 10. 4% for Provident Financial Holdings, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 14. 8% for PROV. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is PROV or ICE or CME or WAFD or JPM more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus WaFd, Inc. 's 3. 69x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, WaFd, Inc. (WAFD) trades at 11. 4x forward P/E versus 22. 0x for CME Group Inc. — 10. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ICE: 38. 0% to $194. 00.

08

Which pays a better dividend — PROV or ICE or CME or WAFD or JPM?

All stocks in this comparison pay dividends.

CME Group Inc. (CME) offers the highest yield at 4. 1%, versus 1. 4% for Intercontinental Exchange, Inc. (ICE).

09

Is PROV or ICE or CME or WAFD or JPM better for a retirement portfolio?

For long-horizon retirement investors, CME Group Inc.

(CME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 28), 4. 1% yield, +262. 4% 10Y return). Both have compounded well over 10 years (CME: +262. 4%, WAFD: +91. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between PROV and ICE and CME and WAFD and JPM?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: PROV is a small-cap income-oriented stock; ICE is a mid-cap quality compounder stock; CME is a mid-cap income-oriented stock; WAFD is a small-cap deep-value stock; JPM is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.